SMO ClinPlus CO.,LTD. (SHE:301257)

China flag China · Delayed Price · Currency is CNY
61.88
+0.92 (1.51%)
At close: Apr 8, 2026
Market Cap4.82B +91.3%
Revenue (ttm)819.09M +1.1%
Net Income121.55M +14.6%
EPS1.38 -9.4%
Shares Out79.00M
PE Ratio44.21
Forward PE44.17
Dividend0.27 (0.44%)
Ex-Dividend DateNov 28, 2025
Volume3,024,584
Average Volume2,369,135
Open60.36
Previous Close60.96
Day's Range59.70 - 62.00
52-Week Range24.18 - 85.00
Beta1.22
RSI55.12
Earnings DateApr 29, 2026

About SMO ClinPlus CO.,LTD.

SMO ClinPlus CO.,LTD. provides site management services in research development in pharmaceuticals, medical devices, and health-related products in China. The company offers early modeling, preliminary preparation plan trial site initiation, on-site execution, and project management services. SMO ClinPlus CO.,LTD. was founded in 2009 and is based in Shanghai, China. [Read more]

Sector Healthcare
Founded 2009
Employees 4,271
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 301257
Full Company Profile

Financial Performance

In 2024, SMO ClinPlus CO.,LTD.'s revenue was 803.73 million, an increase of 5.75% compared to the previous year's 760.04 million. Earnings were 106.43 million, a decrease of -21.01%.

Financial Statements